publishes preliminary numbers for Q4 2019 and financial year 2019 as well as outlook for 2020/21; break-even target on basis of adj. EBIT changed to Q1 2021

• Preliminary revenues of EUR 22.9 to 23.1 million in Q4 2019; revenue increase compared to Q3 2019 due to sales events and Christmas sales; preliminary revenues of EUR 82.3 to 82.5 million in FY 2019
• Preliminary adj. EBIT from EUR -1.9 to -1.6 million (-8.3% to -6.9% margin) in Q4 2019; positive effect from VAT correction of EUR 1.7 million; preliminary adj. EBIT of EUR -13.9 to -13.6 million (-16.9% to -16.5% margin) in FY 2019
• Total cash available of EUR 8.4 million as of December 31, 2019; lower cash burn of EUR 1.3 million in Q4 2019 due to better operating result

Munich, January 22, 2020: SE ("", “Group” or "Company"; ISIN DE000WNDL201) publishes preliminary financial numbers, before final evaluation of trade receivables and inventories, for the fourth quarter (Q4) 2019, the financial year (FY) 2019 as well as an outlook for FY 2020 and 2021.

Revenue growth due to Christmas season and sales events in Q4 2019

Based on preliminary financial numbers, the Group generated revenues of EUR 22.9 to 23.1 million in Q4 2019. This corresponds to growth of 24.1% to 25.2% compared to the third quarter (Q3) 2019 (EUR 18.5 million), which results in particular from the Christmas business and successful sales events in China and in the DACH-region (Germany, Austria, Switzerland). In FY 2019, the Group generated revenues of EUR 82.3 to 82.5 million (FY 2018: EUR 104.8 million) based on preliminary financials. The business in China grew in Q4 2019 but was below the Group's original targets. The reasons for this

Improved adj. EBIT and lower cash burn in Q4 2019; positive impact of VAT correction for China business

Based on preliminary numbers, the Group generated an adjusted (adj.) EBIT of EUR -1.9 to -1.6 million in Q4 2019, which corresponds to an adj. EBIT margin of -8.3% to -6.9%. According to preliminary numbers, in FY 2019 achieved an adj. EBIT of EUR -13.9 to -13.6 million (-16.9% to -16.5% adj. EBIT margin). This is a significant improvement compared to the previous quarter (Q3 2019: EUR -4.7 million and -25.5% adj. EBIT margin) due to better operational performance and the recorded Value Added Tax (VAT) correction of EUR 1.7 million (adj. EBIT effect EUR 1.4 million) related to de

Cooperation with Bodyguard and Holland at Home with focus on the Chinese market in 2020 has signed term sheets for business cooperations with the companies bodyguardpharm GmbH ("Bodyguard") and Holland at Home B.V. ("Holland at Home"). Both companies have also committed themselves to purchase shares as part of the upcoming capital increase with subscription rights through binding commitments agreements.
Bodyguard ( is a German online pharmacy with a strong cross-border e-commerce business to China ( A significant advantage of the future cooperation for is the procurement of medical and pharmaceutical pro

Significant revenue growth and improvement in adj. EBIT expected for 2020; break-even on the basis of adj. EBIT targeted for Q1 2021

For 2020, expects to achieve significant double-digit revenue growth and a significant improvement of adjusted EBIT. This shall be achieved in particular through the cooperations with Bodyguard and Holland at Home as well as other efficiency projects such as the move of the warehouse in Germany and the outsourcing of the IT shop system. Due to lower than targeted revenues for the Chinese market in 2019 and the associated lower starting point for 2020,'s goal of reaching break-even at the beginning of 2020 on the basis of adjusted EBIT changed to Q1 2021. wil

Subscription rights period from January 23, 2020 to February 5, 2020

In the next two weeks, will carry out a capital increase with subscription rights, in which the Company's share capital will be increased from currently EUR 2,989,101.00 by up to EUR 5,171,144.00 to up to EUR 8,160,245.00 by issuing up to 5,171,144 new shares. The subscription price was set at EUR 1.20 per share, so that the maximum gross proceeds of the capital measure will amount to up to 6,205,372.80 Euro. With the gross issue proceeds, intends to strengthen the Company's liquidity position in order to cover the Company's still negative cash-flow until reaching brea

Select key figures for the fourth quarter 2019 and financial year 2019 (preliminary numbers)

Q4 2019Q3 2019Q4 201820192018
Revenues (EUR million)22.9 to 23.118.526.382.3 to 82.5104.8
Adjusted EBIT (EUR million)-1.9 to -1.6-4.7-2.5-13.9 to -13.6-18.5
in % of revenues-8.3 to -6.9%-25.5%-9.7%-16.9 to -16.5%-17.8%
Total cash available (at the end of the period)8.49.711.18.411.1